Monitoring of HVPG during pharmacological therapy: Evidence in favor of the prognostic value of a 20% reduction [1] (multiple letters)

Hepatology

Volumn 39, Issue 6, 2004, Pages 1746-1747

  Garcia Pagán, Juan Carlos ^a   Bosch, Jaume ^a   Burroughs, Andrew K ^b   Thalheimer, Ulrich ^b   Mela, Maria ^b   Patch, David ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BLEEDING; DRUG THERAPY; ESOPHAGUS VARICES BLEEDING; HEMODYNAMICS; HEPATIC VENOUS PRESSURE GRADIENT; HUMAN; LETTER; LIVER VEIN; MONITORING; PRESSURE GRADIENT; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RELIABILITY; VENOUS PRESSURE;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; GASTROINTESTINAL HEMORRHAGE; HEPATIC VEINS; HUMANS; HYPERTENSION, PORTAL; PROGNOSIS;

EID: 2542598569     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20249     Document Type: Letter

References (0)